FUSION PHARMACEUTICALS INC - COM (FUSN)

CUSIP: 36118A100

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
28,182,825
Share change
-399,835
Total reported value
$88,776,644
Price per share
$3.15
Number of holders
28
Value change
-$1,248,182
Number of buys
6
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 36118A100?
CUSIP 36118A100 identifies FUSN - FUSION PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FUSION PHARMACEUTICALS INC - COM (FUSN) as of Q4 2022

As of 31 Dec 2022, FUSION PHARMACEUTICALS INC - COM (FUSN) was held by 28 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,182,825 shares. The largest 10 holders included JOHNSON & JOHNSON, ORBIMED ADVISORS LLC, FEDERATED HERMES, INC., CANADA PENSION PLAN INVESTMENT BOARD, ADAMS STREET PARTNERS LLC, FMR LLC, TPG GP A, LLC, BRAIDWELL LP, Pivotal bioVenture Partners Investment Advisor LLC, and Artal Group S.A.. This page lists 28 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.